Healthcare Industry Type 1 Diabetes (T1D) Market Size

Your Catalyst To a Lucrative Business
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth,
Trends and Forecasts to 2024 | Hexa Research
"Type 1 diabetes market size was valued at USD
25.52 billion in 2016 and is expected to exhibit
rewarding growth by 2024"
The global type 1 diabetes market is expected to reach USD 25.52 billion by 2024. A significant increase in the
prevalence of type 1 diabetes coupled with Rigorous research & development activities to introduce novel
formulations drives the T1D market growth.
Sedentary lifestyles, unhealthy diet habits coupled with rising obesity rates will further enhance the uptake of
various types of insulin for the treatment of this disorder. Though this type of diabetes is rare still the number
of cases is increasing by 3% every year according to the data enumerated by the International Diabetes
Federation (IDF).
Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel
insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the
other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin
coupled with other conditions such as cardiac disorders, kidney disease among others. This affe cts the
respective countries and their national healthcare systems. For instance, the expenditure on diabetes
management accounts for around 5% to 20% of the total healthcare spending.
Rapid-acting, long-acting and premix analogs are the three major types of insulin analogs administered to the
patients. These insulin types when delivered duplicate the action of natural insulin and avoid the excess release
of glucose in blood cells. The market penetration of long-acting insulin products is higher as compared to other
two types, however, during the forecast period, the uptake and acceptance of rapid and premix analogs are
Follow Us: